Alumni

This person is a member of Sanger Institute Alumni.

Alexander combines insights from genetics and spatial transcriptomics to understand how aberrant differentiation of cortical cell types can cause disease symptoms in neurodevelopmental disorders.

Previously, he was a graduate scientist at AstraZeneca, where he contributed to various parts of the drug development process for type 2 diabetes.

My timeline

 

My publications

Loading publications...